51: Jorge Santos da Silva: Visão de CEO de startup biotecnológica

Notas do episódio

Neste episódio do Podcast CRUZAMENTO, André Correia e Daniel Guedelha conversam com Jorge Santos da Silva, Fundador e CEO da MoonLake Immunotherapeutics sobre biotech, investimentos e inovação e, sobre como Portugal é visto por alguém com uma grande experiência internacional. Jorge Santos da Silva, is a co-Founder of MoonLake and has served as the Chief Executive Officer of MoonLake since July 2021, being also a Director of the Board. Prior to MoonLake, he was at McKinsey & Company, Inc. from September 2007 to June 2021, where he was a Senior Partner and led the Pharmaceutical & Medical Products Practice, the Biotech group and the Biosimilars group and advised international biopharmaceutical and biotechnology companies on corporate and business-unit strategy, commercial operating models, R&D, organizational design, M&A and joint ventures. Dr. Santos da Silva was a Postdoctoral Fellow at Cold Spring Harbor Laboratory, NY (USA) and holds a Ph.D. in Neuronal Cell Biology from the University of Turin (Italy) and a MSc in Molecular Biology from the University of Glasgow — Institute of Biological and Life Sciences (United Kingdom) and the European Molecular Biology Laboratory, Heidelberg (Germany). He is also a professor and Board Advisor at the School of Medicine at the Minho University in Portugal. Outras referências feitas no episódio: MoonLake Immunotherapeutics Contactos: CruzamentoPodcast.com cruzamentopodcast@gmail.com LinkedIN: Cruzamento Twitter: @cruzamentofm Facebook: @podcastcruzamento YouTube: Podcast Cruzamento